Revelation Biosciences (REVB) Property, Plant & Equipment (Net) (2021 - 2026)
Revelation Biosciences (REVB) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.06 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.64 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 554.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 107.22 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Revelation Biosciences | 4.17 Mn | -7.33 Mn | - | 172,032.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 172,032.00 |
| Jun 30, 2026 | 172,032.00 |
| Dec 31, 2025 | 18,067.00 |
| Dec 31, 2025 | 18,067.00 |
| Sep 30, 2025 | 23,919.00 |
| Sep 30, 2025 | 23,919.00 |
| Jun 30, 2025 | 35,170.00 |
| Jun 30, 2025 | 35,170.00 |
| Mar 31, 2025 | 42,390.00 |
| Mar 31, 2025 | 42,390.00 |
| Dec 31, 2024 | 56,332.00 |
| Dec 31, 2024 | 56,332.00 |
| Sep 30, 2024 | 81,242.00 |
| Sep 30, 2024 | 81,242.00 |
| Jun 30, 2024 | 70,774.00 |
| Jun 30, 2024 | 70,774.00 |
| Mar 31, 2024 | 77,994.00 |
| Mar 31, 2024 | 77,994.00 |
| Dec 31, 2023 | 65,084.00 |
| Dec 31, 2023 | 65,084.00 |